chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Runny nose; fever; cold; chills; muscle aches; This is a spontaneous report from a contactable consumer. This female consumer reported for herself. A 24-years-old non-pregnant female patient (not pregnant at the time of vaccination) received BNT162B2 (PFIZER-BIONTECH COVID-19 Vaccine, solution for injection, Batch/Lot number was not reported), via an unspecified route of administration, administered in Arm Left on 12Mar2021 at 19:45 (24-year-old at the time of vaccination) at a dose number unknown, single for covid-19 immunization. The patient medical history and concomitant medications were not reported. The patient had not received any vaccine within four weeks. The patient had no covid prior to vaccination. The patient was not tested since vaccination. On 13Mar2021, the patient experienced runny nose, fever, cold chills and muscle aches. The outcome of the events were recovering.  No follow-up attempts are possible; information about lot/batch number cannot been obtained.
Rash developed on torso and back and continued to spread on stomach and in groin area. Per dermatologist it is pityriasis rosea-like in appearance. Mildly itchy. Been taking a topical steroid prescribed by a dermatologist-triamcinolone that seems to be abating it. Evidence of rash has lasted over three weeks.
Pt c/o numbness in hands & feet & ataxia.  Nothing objective upon exam by physician.
1st dose 15Jun2018, 2nd not yet; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a 60-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (1st dose received on 15th June 2018 with batch number B9739 and expiry date 22nd November 2020).   On an unknown date, the patient did not receive the 2nd dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced incomplete course of vaccination (Verbatim: 1st dose 15Jun2018, 2nd not yet). The outcome of the incomplete course of vaccination was unknown.   Additional Information: GSK receipt date:17-MAR-2023 The pharmacist reported that a patient never received the second dose.   At the time of reporting, a second dose had not been administered. The reporter consented to follow up. Till the time of reporting, the patient did not receive 2nd dose of Shingrix, which led to incomplete course of vaccination.
Flu like symptoms; Sick feeling; This case was reported by a consumer and described the occurrence of influenza-like symptoms in a 59-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, less than a year after receiving Shingrix, the patient experienced influenza-like symptoms and feeling unwell. On an unknown date, the outcome of the influenza-like symptoms and feeling unwell were recovered/resolved.   It was unknown if the reporter considered the influenza-like symptoms and feeling unwell to be related to Shingrix.  Additional information received were as follows: The age at vaccination was not reported. A year ago from the reporting date, the patient received 1st dose of Shingrix. The patient experienced sick feeling and flu like side effects. Because of shortages the patient was supposed to get his second shot on the reporting date. The patient asked whether there was anything he could do to prevent the sick feeling that comes with it. For tolerance to 2nd dose, refer linked case US2019192807.
Inconsolable crying after waking from nap. Left thigh edematous and red from crease of groin to knee.
Around 8 hours after the vaccine I experienced: sudden non-menstrual related uterine cramping, abnormal vaginal discharge, increased vaginal discharge, intense pelvic pain, body aches, headache, swollen lymph nodes, dizziness, extreme nausea, diarrhea
abdo cramps, diarrhea 8hr p/vax for 48 hr, chills that resolved p/48hr then on 10NOV devel swollen lymph glands, sore throat, t100.6, gen malaise, fatigue, joint pain 3-4 days;only lingering aches remain;
Itchy around the injection site; Hardness around the injection site; Redness around the injection site; Fever; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (Itchy around the injection site), VACCINATION SITE INDURATION (Hardness around the injection site), VACCINATION SITE ERYTHEMA (Redness around the injection site) and PYREXIA (Fever) in a 45-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 046A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 31-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Apr-2021, the patient experienced VACCINATION SITE PRURITUS (Itchy around the injection site). 01-Apr-2021, the patient experienced VACCINATION SITE INDURATION (Hardness around the injection site), VACCINATION SITE ERYTHEMA (Redness around the injection site) and PYREXIA (Fever). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, VACCINATION SITE PRURITUS (Itchy around the injection site), VACCINATION SITE INDURATION (Hardness around the injection site), VACCINATION SITE ERYTHEMA (Redness around the injection site) and PYREXIA (Fever) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.
Day after shot (1/15/2021) redness at injection site with extreme arm soreness?cleared up two days. Now 9 days later (1/23/2021) the same redness and soreness has returned at injection site.
mom states pt had shot on Wed & began having jerking, like hiccups on Thursday which has cont upon moms return home this AM from 3rd shift job; pt cont to have jerking motions & mouth is swollen;
Normal day on Saturday. On Sunday morning stiff neck started and general body malaise. Called pharmacist by Sunday afternoon; pharmacist advised to take Tylenol but did not have any. On Sunday did not go out as planned because did not feel well. Experienced fever all day up to 99.5 (2 degrees up than normal), felt lethargic, and uncomfortable. Patient did not take any medicine for the fever. By Monday fever was gone, had unpleasant taste in mouth, and body stiffness. Went to water aerobics class to stretch to help with stiffness. Today doing well; still don't have a lot of energy and there is a bit of swelling at the site of the injection.
This is a spontaneous report from Pfizer Medical Information for a contactable reporter. A 2-month-old, female consumer received PREVNAR 13 in Mar2013. Relevant medical history included allergic to dairy products since an unknown duration. Relevant concomitant medications included DTAP/IPV/HIB, both in Mar2013. The patient experienced bad allergic reactions within 24 hours of administration of PREVNAR 13 in Mar2013. Relevant laboratory data was none. Therapeutic measures taken in response to the event were none. The patient recovered from the event. Follow-up - (20-JULY-2013) Follow-up attempts completed. No further information expected.
throat infection; sore throat; swelling in her eyes; fever; This is a spontaneous report from a contactable consumer (patient's mother) via Medical Information Team. A 19-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot number: Unknown), via an unspecified route of administration on 01Apr2021 as dose 1, single for covid-19 immunisation. The patient medical history and concomitant medications were not reported. She said that her daughter had a fever and a little bit of a throat infection and was prescribed to take antibiotics, it's her 3rd day of taking it. Last week she was prescribed antibiotics for a sore throat and swelling in her eyes. She reported she was negative for Covid and strep throat. She stated her 19 y/o daughter was due to receive her second Pfizer Covid vaccine dose tomorrow 23Apr2021. She was asking if she should continue getting the 2nd dose today or should they wait a week or 2. She wanted to know if she can safely take the second dose of the vaccine while on antibiotics. The patient underwent lab tests and procedures which included SARS-CoV-2 test: negative. Therapeutic measures were taken as a result of all the events and included treatment with antibiotics. The outcome of the events was unknown.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
After my J&J vaccine, I experienced severe headaches all day starting from 03-16-2021 lasting till 03-17-2021.  I had some soreness at the injection site. The headache pain was located on the top right of my head towards the back, above my right ear. I took two Tylenol as well as an Aleve as pain medication. I had an U/S of the right leg to check for main vein in my leg to check for any blood clots. The results of my exam were negative.   I have been fine since these symptoms.
soreness on the arm; minor chills; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (soreness on the arm) and CHILLS (minor chills) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 02-Mar-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (soreness on the arm) and CHILLS (minor chills). At the time of the report, PAIN IN EXTREMITY (soreness on the arm) and CHILLS (minor chills) outcome was unknown.            Concomitant product use was not provided by the reporter.  Treatment information was not provided.  Action taken with mRNA-1273 in response to the events was not applicable.
1 a.m. the next morning: chills, headache, body aches, fatigue, lasting about 24 hours.  Ongoing:  All inflammatory conditions are worse:  arthritis pain and flareups more often, asthma more severe and needing more medication, seasonal allergies more severe and year round
Vaccine exposure during pregnancy; This spontaneous prospective pregnancy case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy) in a 30-year-old female patient (gravida 1) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 004M20A and 012A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. The patient's last menstrual period was on an unknown date and the estimated date of delivery was 28-May-2021. On 27-Jan-2021, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy). On 24-Feb-2021, MATERNAL EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy) had resolved.            The patient's medical history was not provided Relevant concomitant medications were not reported.  Treatment information was not provided.
After two days of injection - pt complaining of swelling, tenderness, on touch at the site.
Information has been received from a medical assistant referring to an unspecified number of patients of unknown age and gender. On an unknown date the patients were vaccinated with doses of improperly stored VAQTA lot # L018499, expiration date 25-FEB-2017, (dose, dose #, route and application site were not reported). No symptoms reported. This is one of several reports received from the same source. Additional information has been requested.
My arm where it was administered has been painful to touch/Sometimes just sitting I feel pain in the arm.; My arm where it was administered has been painful to touch; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non-HCP), Program ID: The reporter is the patient.  A 51-year-old female patient received BNT162b2 (BNT162B2), on 16Oct2021 at 10:30 as dose 3 (booster), single (Lot number: FH8027) at the age of 51 years, in arm for covid-19 immunisation. The patient had no relevant medical history. The patient's concomitant medications were not reported. Vaccination history included: BNT162b2 (Dose 1st, Time (24hr): 11:30 AM, Batch/Lot number: Not available / Provided at time of report completion), administration date: 13Mar2021, when the patient was 50-year-old, for COVID-19 Immunization; BNT162b2 (Dose 2nd, Time (24hr): 11:00 AM, Batch/Lot number: Not available / Provided at time of report completion), administration date: 10Apr2021, when the patient was 50-year-old, for COVID-19 Immunization. The following information was reported: VACCINATION SITE PAIN (non-serious) with onset Oct2021, outcome "unknown", described as "My arm where it was administered has been painful to touch"; PAIN IN EXTREMITY (non-serious) with onset Oct2021, outcome "unknown", described as "My arm where it was administered has been painful to touch/Sometimes just sitting I feel pain in the arm.".  Additional information: Ever since the third dose (Booster) on 16Oct2021, her arm where it was administered has been painful to touch as well as whenever she carries anything heavy in that hand/arm. Sometimes just sitting she feel pain in the arm. In addition, 6 weeks after the 4th booster of 10Nov2022 she tested positive for COVID-19.
This spontaneous report as received from a registered nurse refers to a patient of unknown age. On 31-DEC-2013 the patient was mistakenly administered with VARIVAX (Merck) (lot number, dose, route and injection site were not reported) instead of ZOSTAVAX. No adverse effects reported. The outcome and action taken were not provided. Additional information has been requested.
Patient was 15 years old at the time of vaccination. 2 days away from 16th birthday. No adverse events noted.
Bells Palsy. Partial pacial paralysis.  All effects happened on the left side, where vaccine was taken.   Debilitating job pain. Affects my work as well as eating and consuming beverages. Loss of function of left eye (Manually close eye lid)   Affects looking at work computer for extensive periods of time.   Other side effects: headaches, trouble sleeping, facial twitching.
1x2cm  urticaria reaction to thighs from MMR and Varicella 5-10 minutes after administration. Vistaril administered to pt IM and sx resolved.
covid 19; This spontaneous case was reported by a patient family member or friend and describes the occurrence of COVID-19 (covid 19) in an adult female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received fifth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced COVID-19 (covid 19). At the time of the report, COVID-19 (covid 19) had resolved.            No concomitant medications were reported.  The patient had received 5 doses of the COVID-19 vaccine, but still got COVID. The reporter stated that, she was doing better now. The reporter did not know if she had received the Moderna COVID-19 vaccine or Pfizer.   No treatment medications were reported.   Reporter did not allow further contact
COVID-19; COVID-19; This is a spontaneous report received from a contactable reporter (Consumer or other non HCP). The reporter is the patient.  A 34-year-old male patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 22Sep2022 as dose 4 (booster), single (Lot number: GJ2524) at the age of 34 years, in left arm for COVID-19 immunisation; COVID-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for COVID-19 immunisation. The patient's relevant medical history included: "GERD" (unspecified if ongoing); "Seasonal Allergies" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "not recovered" and all described as "COVID-19". The patient underwent the following laboratory tests and procedures: COVID-19 test: (unspecified date) Positive; (2023) Negative, notes: feeling fine after finishing Paxlovid; (2023) Positive, notes: positive again. Therapeutic measures were taken as a result of drug ineffective, COVID-19 with Paxlovid from 24Mar2023 to 28Mar2023.
Received the Moderna Covid 19 vaccination 2 days ago.  Red blotches appeared on my breasts and abdomen after sitting in the sun for approximately 1/2 hour.  They were not painful or itchy and seem to be fading after about an hour.
tender quarter size area left ECU tender area with left wrist deviation & painful motion.  Occurred night after taking 2nd dose of oral TYPHOID.  Had received HEP A & TDAP on 1/21/09.  Oral TYPHOID 1/26 & 1/28/09.  Treated with VOLTRAN and referred to Ortho for coronet
This spontaneous report was received from a physician via a company representative referring to a male patient of unknown age. The patient's pertinent medical history, concurrent conditions and concomitant medications were not reported. The patient's drug reactions/allergies were unknown by reporter. On unknown dates, also reported as "years ago, when the patient was an adolescent", he received two doses of M-M-R II for prophylaxis (strength, dose, route, Lot # and expiration date were not reported). On an unknown date, it was discovered that, during a routine titer level testing as part of screening for entering nursing school, the patient's titer level for mumps was good but the patient's titer level for both measles and rubella were low. Because of that low titers, the patient was prescribed to receive an additional dose of M-M-R II. He was scheduled to receive the additional dose on Monday, 06-NOV-2017; thus, the physician reconstituted the additional dose on this same date in preparation for giving the shot, but the physician chose to delay the vaccine administration because the patient received an unspecified routine screening injection test for tuberculosis on this same date, 06-NOV-2017 and to not administer the vaccine concomitantly with the shot test for tuberculosis. The physician then, refrigerated the reconstituted M-M-R II for prophylaxis (strength, dose, route, Lot # and expiration date were not reported) until 08-NOV-2017, when it was administered; procedure which was not recommended in the product label but this was considered the treatment for the adverse experiences reported. Additionally, it was reported that the physician would re-vaccinate the patient or would run the titers again. At the reporting time, the outcome of measles antibody negative and rubella antibody negative was unknown. The causality assessment between the events and vaccination with M-M-R II was not provided.
vomiting; This case was reported by a pharmacist via call center representative and described the occurrence of vomiting in a 55-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, 4 hrs after receiving Shingrix, the patient experienced vomiting. On an unknown date, the outcome of the vomiting was unknown.   It was unknown if the reporter considered the vomiting to be related to Shingrix.  Additional case details were reported as follows: The age at vaccination was not reported. The patient received Shingrix and had vomiting. Limited information was provided by the reporter because the patient did not received the first injection at their pharmacy.
I am pregnant 16 weeks at the time of shot. Due August 20, 2021.  After my shot, I had a small bump/nob at injection site. Today (7 days after shot), it was itchy. I finally looked at it and it is red, swollen, and hot to the touch. I read that it is harmless but thought I would report it anyways. I ha e had no other symptoms.
Headache, muscle aches, chills, mild nausea (no vomiting)
5/14/21: Approx. 4-5 hours after 2nd dose, developed full body hives, headache, fatigue, body aches, lump in throat. Treated with Tylenol and Benadryl. On 5/15/21, at 6pm called Pharmacy and instructed to go to ER. ER administered epi-pen, prednisone, Benadryl, Pepcid and Tylenol. 5/17/21: Appointment w/ Allergist and advised to take Zyrtec, Allegra, Singular, and Pepcid, until symptoms resolve. If still symptomatic after 6-weeks, call Allergist back and re-evaluate.
A painful burning on administration, later an aching and heat at site of inj. Loss of mobility, next day - slightly better but a weakness and fatigue.
Dizziness Narrative: C/O DIZZINESS GIVEN JUICE VS 120/65 HR 80
after pt recv vax exp severe watery diarrhea w/nausea unsure if temp present.
Tenderness in arm currently 6 days later but slowly getting lighter Itching at injection site immediately following  injection
Several days-weeks after receiving the covid vaccine, I noticed my heart rate dropping when I was attempting to workout
Menstrual related symptoms since completing the series.  Symptoms include extreme cramping with heavy bleeding.  Before vaccinating bleeding was normal and pain/cramping was mild to non-existent.  This is true for my entire 25 years of menstruating.  Periods have also become erratic.  So far 28 days, 35 days, 35 days, 42 days.  Periods before vaccinating have been very regular except when pregnant.  Even while breastfeeding periods have always been regular.    I also in the summer experienced mild cardiac symptoms that I did not seek care for.  I would feel as though there was an air bubble in my chest and I finally linked the episodes to low heart rate.  I normally run in the high 80s and 90s for resting heart rate.  When these episodes were happening my heart rate was dipping into the 50s and 60s.  I did not seek treatment as the episodes were transitory.  I know now that heart related side effects are probably a lot more common than is known.  I seem to have resolved from this issue.  I wanted to report even though I have little data on this issue as I believe the heart issues can be serious for some and more study is needed into this issue.  Thank you.